Upcoming webinar: Speech as a biomarker in Ataxia: What can it tell us & how should we use it?


E2di2R_XMAA02Cl.jpgRedenlab CSO, Adam Vogel, will be presenting at the upcoming joint webinar with the European Reference Network for rare or low prevalence complex diseases, Neurological Diseases (ERN-RND), Neuromuscular Dieseases (ERN EURO-NMD), and European Academy of Neurology. The subject of the webinar is Speech as a biomarker in Ataxia: What can it tell us & how should we use it. Sign up here!

Related Post

  • Posted on 15 July, 2022
    MEDIA RELEASEFRIDAY 15 JULY 2022 As many as 70% of people who experience stuttering have a family member who also...
    • Posted on 28 November, 2021
      Dr Garcia joins the Redenlab science team to drive its language analytics pipeline for cognitive-linguistic disorders like fronto-temporal dementia. Adolfo...
      • Posted on 17 October, 2021
        Redenlab’s latest iOS application provides state of the art audio capture, storage and analysis of speech and language data for...